We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 354 → 5 (-349)

99.54% less ownership

Funds ownership: 99.58% → 0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 29 → 0 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
344
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$822M
2
BlackRock
BlackRock
New York
-$784M
3
PCM
Pentwater Capital Management
Florida
-$500M
4
State Street
State Street
Massachusetts
-$286M
5
UBS Group
UBS Group
Switzerland
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
151
Marshall Wace
United Kingdom
– -$4.09M -31,900 Closed
IIM
152
INTECH Investment Management
Florida
– -$4.08M -31,834 Closed
VI
153
Vestcor Inc
New Brunswick, Canada
– -$4.05M -31,565 Closed
Arrowstreet Capital
154
Arrowstreet Capital
Massachusetts
– -$3.79M -29,562 Closed
SEI Investments
155
SEI Investments
Pennsylvania
– -$3.61M -28,131 Closed
Pathstone Holdings
156
Pathstone Holdings
New Jersey
– -$3.52M -27,464 Closed
HIM
157
HGC Investment Management
Ontario, Canada
– -$3.24M -25,298 Closed
EAM
158
Erste Asset Management
Austria
– -$3.22M -25,100 Closed
Citadel Advisors
159
Citadel Advisors
Florida
– -$3.22M -25,094 Closed
VAM
160
Vazirani Asset Management
New York
– -$3.2M -25,000 Closed
State of New Jersey Common Pension Fund D
161
State of New Jersey Common Pension Fund D
New Jersey
– -$2.93M -22,824 Closed
American Century Companies
162
American Century Companies
Missouri
– -$2.92M -22,770 Closed
FCM
163
Frontier Capital Management
Massachusetts
– -$2.78M -21,687 Closed
New York State Common Retirement Fund
164
New York State Common Retirement Fund
New York
– -$2.68M -20,920 Closed
AC
165
Athos Capital
Hong Kong
– -$2.56M -20,000 Closed
MCM
166
Moore Capital Management
New York
– -$2.56M -20,000 Closed
ECM
167
ExodusPoint Capital Management
New York
– -$2.48M -19,351 Closed
Dimensional Fund Advisors
168
Dimensional Fund Advisors
Texas
– -$2.42M -18,907 Closed
Envestnet Asset Management
169
Envestnet Asset Management
Illinois
– -$2.41M -18,816 Closed
ASRS
170
Arizona State Retirement System
Arizona
– -$2.39M -18,651 Closed
BNP Paribas Financial Markets
171
BNP Paribas Financial Markets
France
– -$2.38M -18,556 Closed
Ameriprise
172
Ameriprise
Minnesota
– -$2.33M -18,199 Closed
ProShare Advisors
173
ProShare Advisors
Maryland
– -$2.29M -17,873 Closed
Handelsbanken Fonder
174
Handelsbanken Fonder
Sweden
– -$2.26M -17,651 Closed
Teacher Retirement System of Texas
175
Teacher Retirement System of Texas
Texas
– -$2.21M -17,223 Closed
5 6
7
8 9

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.